|
|
||||||||||||
|
Growth and Development of Smithers Treatment Center, 1990-1998 | ||||||||||||
|
Our strategy and what we actually accomplished during my tenure as
medical director at the Smithers Addiction Treatment and Research Center.
This document was prepared for the incoming
Roosevelt Hospital
administration so they would know what we were about so as not to ruin us.
| ||||||||||||
Introduction
Smithers Treatment Center is a lean and flexible modern
addiction treatment center functioning within the Department of
Medicine at Roosevelt Hospital. We have thrived over the past
eight years while many private treatment centers have closed
because we have embraced, rather than avoided, the challenges
of, 1) the advancements in the understanding of the
neurobiological basis of addiction and, 2) the rise managed
care. In this time of rapid institutional change and the merging
of various clinical services, it is especially important that
the administrative and clinical leadership of both institutions
understand the nature and quality that Smithers represents, our
potential for generating increased funding and prestige for our
parent institutions, and the overhaul and very significant
improvement of clinical and administrative services that our
team has accomplished. This document will briefly trace the
development of the Smithers Center over the past eight years,
analyze our current operations and discuss our potential for
enhancing both the prestige and the bottom line of Roosevelt
Hospital and Beth Israel Medical Center. What We Were
In 1990 Smithers Treatment Center consisted of three
basic services: inpatient (hospital) alcohol and sedative
detoxification, inpatient rehabilitation of alcoholics, and a
small outpatient department. Patients were triaged into one of
these services based entirely on a telephone interview with a
nurse. Within each service there was little individualization of
treatment. For example, patients admitted to the Rehabilitation
Unit stayed 28 days regardless of severity of illness or
particular array of problems. Staff was very comfortable with
alcoholism and with the care and treatment of a predominantly
middle class patient population, but was far less skilled in,
and comfortable with, the treatment of opiate and stimulant
dependence.
Our assessment process was idiosyncratic and cumbersome.
Like all clinical addiction centers of the time, we gathered a
tremendous amount of data from patients into a very long history
form that had evolved over the years. From this various
diagnoses and problems were generated, but since the treatment
we offered was the same for everyone, formally addressing
particular problems was somewhat moot. The data was often
incomplete, and very difficult to access and process given it’s
length and complexity. We had no way of tracking how our
patients were doing either in treatment or afterwards. We could
not say with certainty how many patients who started an
outpatient program were still in treatment three months later,
or which sort of patient had the worst prognosis in our system,
or what percentage of toxicology’s remain positive. Having no
organized data, no outcome analysis or research was possible and
so clinical practice was more the result of evolution than of
thoughtful, evidenced-based, design. The Goals
In 1991 we outlined the elements that comprise modern,
state-or-the-art addiction medicine. We decided that addiction
treatment centers:
·
Must become patient - oriented as opposed to
program – oriented. Good clinical practice and efficiency
demand we deliver targeted treatment to targeted problems · Must base treatment plans on a comprehensive assessment of problems in all life areas (not just the addiction) and that standardized, nationally validated tools be used whenever possible to allow comparison of our population and performance with the published literature and to permit research on our patient population to begin
·
Must have patient tracking and data collection
and analysis built into the administrative and clinical fabric
of the center for two major reasons. One, we will be
increasingly required to demonstrate the efficacy of our
interventions in order to justify referral and payment in a
managed care environment. Two, very little research in addiction
medicine is generated from functioning treatment centers;
rather, in the vast majority of studies, special research
treatment units are established to test one intervention or
another. By building computerized data collection and patient
outcome tracking into the treatment center, we will be in an
excellent position to do important research in the field and
generate significant grant money. This will allow us to continue
to grow and develop in an economic environment where funds for
growth and development are scarce.
·
Must become clinically more diversified and
administratively more flexible. Diversification of treatment
services follows from a thorough assessment generating different
problems that then need to be addressed. Diversification is also
demanded by employing national criteria for patient placement,
which recognize four separate intensities of detoxification, for
example. Administrative flexibility follows from the pressure
from managed care and from the demands of good clinical practice
and efficiency. Not
all patients require a hospital setting for detoxification, and
some that meet criteria for admission to a hospital on day 1 may
become stabilized by day 2 such that treatment can safely
continue in a subacute setting. Treatment centers need to be
able to respond to a patient’s changing clinical condition on
a daily basis, rather than on a weekly or monthly basis as was
the rule in the past.
·
Must clearly define what the core content of
substance abuse treatment is, and prioritize its delivery. As
lengths of stay at all levels of care decrease, we have less and
less time to accomplish the same treatment goals and therefore
need to more carefully design treatment structure and content.
The standard of quality in medicine is evidenced-base treatment,
and successful addiction treatment centers will redesign their
treatment programs along these lines. What We Have Done
Between
1991 and the present we have accomplished the following
concrete, identifiable results in pursuit of the above goals
· Conceptualized, designed and implemented the
Smithers Evaluation Unit (EU).
·
All patients are assessed in the EU prior to
referral to any of our treatment programs. The evaluation is
staged for both clinical and economic reasons. If a patient is
assessed to require detoxification, the rest of the psychosocial
history is deferred until the patient is stable. Patients in
need of acute detoxification are often too intoxicated and/or
ill to be able to complete an exhaustive battery of psychosocial
tests and interviews. This staged assessment system also avoids
spending hours with patients on day 1 only to have 30% drop out
by day 4 conserving our resources for patients who will be
around to benefit from them.
·
Standardized assessment tools are now used
exclusively. The Addiction Severity Index, the Beck Depression
Inventory, the Brief Symptom Inventory, and the Clinical
Institute Withdrawal Scale form the core of our assessment.
Other studies are collected for experimental and trial purposes,
for example, motivational assessments, childhood trauma
questionnaires, and so on. These tests highlight problems or
problem severity that were often missed using our prior patient
database, lend themselves to computerization, and allow us to
collect data of research quality. · Smithers actively participated in the development of the American Society of Addiction Medicine (ASAM) Patient Placement Criteria (PPC). Dr. DeLuca, our Associate Director for Medicine, was a member of the original ASAM committee that created the PPC version 1, and is currently on the ASAM committee charged with producing a computerized version of version 2. We have integrated the concepts and content of the PPC into our assessment and treatment systems. The integration of the EU, the use of standardized assessment tools, and the PPC have transformed Smithers into a patient-oriented system where individualized treatment follows from problems generated by an objective and standardized assessment with treatment initiated in accordance with nationally recognized placement criteria. These changes have also greatly aided us in our communications with managed care organizations because we can see at a glance with the individual patients problems are, how severe they are, and what level of service is indicated.
· Development of a research department.
· Building an infrastructure to support clinical
research proceeded hand in hand with the development of the EU.
The Director of Research, Dr. Jeffrey Foote, and Dr. Alex
DeLuca, who is also a professional database programmer, largely
on their own time and using their own funds for needed software
and development hardware, have designed and produced a computer
database program (“Trax!”) that performs two critical
functions. One, unpaid research assistants recruited from local
colleges and psychology graduate schools enter demographic,
assessment, and research data on all patients coming through the
EU. Follow up studies can be used to follow a patient’s
progress in recovery. Two, the program collects weekly tracking
data on every patient in treatment at Smithers, including
attendance data, use of sobriety medications, urine toxicology
results, etc. This powerful capability has tremendous
implications for quality of treatment, third party payment, and
the advancement of research in addiction medicine. For example,
we can now find out for certain if preceding our regular group
therapy with a brief motivational intervention is associated
with greater retention in treatment and improved patient
outcomes. On another level, the tracking system allows
supervisors to identify problems with particular treatment
programs or counselors and investigate and remedy the situation.
· The design of the EU, the existence of a research
infrastructure, and our varied treatment population has made
Smithers a very attractive environment for clinical research in
addiction medicine. We have entered into a partnership with the
National Drug Research Institute (NDRI) with whom we received
funding for the first grant we applied for. The NIAAA is
providing 1.5 million dollars over three years for a study of
the ASAM PPC, which began in 9/97. We are in the process of
applying for a grant to study an innovative group motivational
treatment we have designed. Several other non-funded projects
are being done, and five papers by various members of our team
have been accepted for poster presentation at the Research
Society for Alcoholism, 1998 Annual Scientific Meeting. We are
planning to meet the summer ’98 deadline for a NIDA grant to
study outpatient detoxification.
· Consolidation of services and clinical
administration. · In 1995 we moved our entire outpatient department, the EU, all administrative services, and the detoxification unit into the newly renovated Roosevelt Hospital. We have planned the move of our rehabilitation services into the hospital as well, though this latter initiative has been stalled due to unresolved negotiations with the Smithers family. Physical consolidation of services facilitates the clinical and administrative flexibility described above.
·
In 1997 we streamlined the supervisory structure
of our outpatient services by replacing five part time staff
members each of whom oversaw a separate program with two full
time supervisors overseeing the entire outpatient department.
This has greatly reduced the culture of fragmentation that had
existed and has permitted us to more easily and efficiently plan
and implement improved outpatient services as outlined below.
·
Diversification, addition and improvement of
clinical service.
· All Smithers services have been converted from
fixed-length-of-stay programs to variable- length-of-stay using
ASAM Continuing Stay and Discharge Criteria and frequently
stepping up or down the intensity and content of treatment based
on clinical progress. This has made us much more attractive to
managed care organizations for whom any fixed-length-of-stay
policy is anathema.
· Diversification of detox services.
· We have pioneered the use of innovative detox
regimens. For example, we are the only center in the City to
routinely offer inpatient rapid opiate (clonidine to naltrexone)
detoxification and as such receive referrals from other centers
to manage difficult cases that have failed outpatient
detoxification efforts and from managed care organizations who
appreciate the added value this treatment represents.
·
We are now able to offer detoxification services
in the inpatient hospital setting, the subacute inpatient
(rehab) setting, and as an outpatient service. The Short Term
Assessment and Treatment (STAT) Unit was implemented in 1994
after discussions with HIP regarding their need for an
alternative to hospital-based detox. The STAT unit is a
sub-acute inpatient service for patients who require inpatient
detoxification for social, psychiatric, or medical reasons but
who do not meet criteria for an acute care hospital bed. After
careful retrospective and prospective review, we determined that
approximately 30% of the patients we had historically admitted
to the acute hospital setting could be safely and effectively
cared for in the sub-acute program. We started providing outpatient
detoxification in 1997 and demand for the service has
steadily grown, and clearly this is the wave of the future.
Smithers has become recognized as a leader in outpatient
detoxification. Our Associate Director for Medicine was asked by
the Office of Alcohol and Substance Abuse (the NYS regulators)
to assist with the writing of the new regulations for outpatient
detox units soon to be licensed by the state. He is also
involved in producing a curriculum for State mandated course
that applicants for said license will have to take. · We plan further expansion of outpatient detox programs (day hospital detox, 23 hour observational beds). Again, this variety of intensities of service and the ability to quickly and easily move patients from one level of care to another make us very attractive to managed care and other referral sources and provide a veritable gold mine of potential clinical research studies. [Top of Page]·
Expanded clinical services other than
detoxification.
· Group motivational interviewing (GMI). Our most
recent treatment innovation, we designed a group version of the
well published motivational interview technique as an
introduction to treatment for patients ambivalent about
committing to protracted treatment, and as an experimental
intervention to determine if ‘pre-treatment’ with GMI
enhances subsequent treatment outcomes. The pilot study is
complete and we are finishing the process of submitting the
study for grant funding.
·
Nurses Helping Nurses Program, developed in
response to the increasing numbers of nursing professionals
seeking our services and to the lack of excellent, thorough
assessment and treatment services tailored to this population in
NYC.
· Trauma Group. A pilot implementation of our
concept of manual-driven treatment (see below). Having noted the
literature documenting the extremely high proportion of addicts
having histories of major trauma (rape, incest, sexual abuse,
and domestic violence) and the relationship of traumatic
experience to relapse, we designed a series of group sessions as
additional therapy for patients with this history.
· First Step Program. This was our first attempt at
breaking down the rigidity of program-oriented treatment which
many patients were unable to conform to. Begun in 1992, the
First Step Program was designed as a Case Manager model of
treatment in which the counselor individually tailored a
treatment regimen for patients who were having difficulty
staying connected to treatment in traditional groups. It has
allowed us to keep patients in treatment that we had previously
lost.
· Day Program 2. In the mid-1970’s Smithers
opened one of the first intensive outpatient programs for inner
city alcoholics and addicts in need of major structure and
support. This was Day Program 1. In 1985 we started the Smithers
Evening Rehabilitation Program (SERP) to meet the needs of
employed persons requiring daily intensive treatment. Day
Program 2 is our most recently instituted intensive outpatient
program. It meets in the mornings and is targeted at employable
addicts in need of intensive outpatient treatment and assistance
and support in re-integrating into the work force.
· Hospital consultation service. In 1996 we
implemented an addiction consultation service in Roosevelt
Hospital for a variety of reasons:
· To find and offer ongoing treatment to med/surg
and psychiatry patients with drug and/or alcohol problems.
· To provide a clinical service to the staff and
patients of Roosevelt Hospital by assisting with difficult cases
on the ward and arranging timely and effective discharging
planning.
· To increase the visibility of Smithers in the
hospital and improve relations with other departments · To increase awareness of addiction problems and treatment among the Hospital staff and offer ongoing assistance and training. The consultation service was significantly improved in 1998 with better coordination of services with the Substance Abuse Liaison at the request of Dr. Barrish.
· Core 20 initiative. We are changing our
outpatient treatment model from a 1970’s milieu group therapy
without specified content and style to a modern manual-driven
approach based on cognitive-behavioral and motivational
therapies. The improved efficacy of this treatment model is
supported by research and has other advantages as well. It will
now be possible to measure the amount and type of treatment
delivered and track the patient outcomes with our computer
tracking system. This is an active area of research in addiction
medicine and we intend to be major contributors in this arena in
the very near future. The conversion to this improved treatment
structure will be complete by the fall of 1998. [Top of Page]
| ||||||||||||
|
||||||||||||